Condition
Chronic Myelogenous Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Chronic Myelogenous Leukemia clinical trials that are recruiting, at sites in 33 countries (most in United States (8), Brazil (2), Canada (2)). By phase: Phase 2 (4), Phase 4 (1), Phase 1 (1). The most active sponsors are Masonic Cancer Center, University of Minnesota (2), Novartis (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 33Countries
Newest Chronic Myelogenous Leukemia clinical trials
All recruiting trials (9)
-
Asciminib for children and teens with Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase
This study will try asciminib as a treatment for children aged 1 to under 18 with Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase, including newly diagnosed patients and those who are resistant or intolerant to prior TKIs, with or without the T315I mutation.
-
Study of crushed venetoclax tablets dissolved in liquid for pediatric patients
This study tests if crushing venetoclax tablets and mixing them with liquid helps children with blood cancers absorb the medication better and stay safe while taking it.
-
Evaluating TGRX-678 for patients with advanced Chronic Myelogenous Leukemia
This study is testing a new drug called TGRX-678 to see if it can help people with advanced Chronic Myelogenous Leukemia who haven't had success with other treatments.
-
Stem cell transplant using a specific preparative regimen for blood cancers
This study is testing a new way to prepare for a stem cell transplant using a special combination of medications and radiation to see if it helps people with acute leukemia who are in remission.
-
Comparing T Cell Depletion Methods for Blood Cancer Treatment
This study is testing different ways to prevent complications after a stem cell transplant for blood cancer to see which method helps patients stay healthy and cancer-free longer.
-
Long-term safety treatment for chronic myelogenous leukemia patients
This study is testing the long-term safety of a medication called asciminib for patients with chronic myelogenous leukemia who have already been part of another study.
-
Hematopoietic stem cell transplant for blood cancers
This study is testing two different ways of doing stem cell transplants for people with blood cancers to see which method works better and is safer.
-
Collecting and reporting data on patients receiving stem cell transplants
This study is trying to gather and share information about patients getting stem cell transplants for blood cancers to better understand how well these treatments work.
-
Review of Chronic Myelogenous Leukemia Patients Treated with Imatinib
This study looks at how well imatinib works for people with Chronic Myelogenous Leukemia in everyday settings by reviewing their treatment experiences and outcomes.
Related topics
Quick answers
How many Chronic Myelogenous Leukemia clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 33 countries. The most sites are in United States (8 trials), Brazil (2 trials), Canada (2 trials), China (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.